PJP

Tactical Allocation Channel

4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat

By Ben HernandezApril 9, 2019

Innovative ETFs Channel

Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results

By Max ChenFebruary 28, 2019

Equity ETFs

ETF Plays for a Divided Midterm Elections

By Max ChenOctober 22, 2018

Equity ETFs

Pharmaceutical ETFs Could Maintain Their Momentum

By Max ChenSeptember 6, 2018

Equity ETFs

July Could Be a Volatile Month for Pharma ETFs

By Max ChenJuly 3, 2018

Equity ETFs

6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’

By Max ChenMay 11, 2018

Equity ETFs

Get Lucky With 10 Saint Patrick’s Day ETFs

By Amiya MorettaMarch 16, 2018

Alternative ETFs

Direxion Resuscitates Leveraged Pharmaceutical ETF

By Max ChenNovember 15, 2017

Equity ETFs

Biotech, Pharma ETFs Leave Pricing Drama Behind

By Max ChenSeptember 15, 2017

Smart Beta Channel

Write A Prescription For This Pharma ETF

By Tom LydonJuly 10, 2017

Equity ETFs

How a New SCOTUS Ruling Could Affect Pharma ETFs

By Tom LydonJune 14, 2017

Equity ETFs

Drug Makers, Pharma ETFs Face a Tough Earnings Season

By Max ChenApril 24, 2017

Equity ETFs

Look to These Sector ETFs in Case of an Election Day Surprise

By Max ChenNovember 4, 2016

Equity ETFs

Finding Pharmaceuticals ETFs With Rebound Potential

By Tom LydonMay 4, 2016

Equity ETFs

The Best Performing ETFs Since the Financial Downturn

By Max ChenMarch 9, 2016

Featured

Major Pharma Merger Boosts ETFs

By Tom LydonOctober 29, 2015

Featured

Political Placebo: Pharma Regulation

By Tom LydonOctober 12, 2015

Featured

A Long-Term Healthcare Winner

By Tom LydonSeptember 24, 2015